Home › Funds › Synergy Asset Management, LLC › ORKA
Synergy Asset Management, LLC position in ORKA
ORUKA THERAPEUTICS INC · Health Care
Synergy Asset Management, LLC reported holding 127,852 shares of ORKA (ORUKA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$10.6M, representing 0.98% of its reported portfolio and ranking #27 among its reported holdings. Synergy Asset Management, LLC has disclosed ORKA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Synergy Asset Management, LLC's ORKA position evolved
Synergy Asset Management, LLC first disclosed a stake in ORKA in Q4 2025 at 458,946 shares (US$13.9M). The position peaked in Q2 2026 at 356,301 shares, worth US$33.9M. Across 4 filings, Synergy Asset Management, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 127,852 shares valued at US$10.6M — a reduction of -228,449 shares quarter over quarter.. Notable position changes include a 25% trim in Q2 2026 (shares fell 12% over the following quarter), a 64% trim in Q3 2026 (shares rose 26% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 458.95K | $13.91M | New |
| Q1 2026 | 476.20K | $23.36M | Add |
| Q2 2026 | 356.30K | $33.91M | Reduce |
| Q3 2026 | 127.85K | $10.65M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ORKA and 13F data
ORKA (ORUKA THERAPEUTICS INC) is a Health Care company. 87 other funds we track also report a position in ORKA — the largest reported positions include Venrock Adviser, LLC (US$394.8M), Fairmount Funds Management LLC (US$352.6M), RTW INVESTMENTS, LP (US$298.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ORKA
- Venrock Adviser, LLC 4.15M sh · $394.81M · Q2 2026
- Fairmount Funds Management LLC 3.71M sh · $352.63M · Q2 2026
- RTW INVESTMENTS, LP 3.14M sh · $298.74M · Q2 2026
- Paradigm Biocapital Advisors LP 2.14M sh · $204.09M · Q2 2026
- Deep Track Capital, LP 1.93M sh · $183.30M · Q2 2026
- Bellevue Group AG 1.66M sh · $157.71M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.55M sh · $147.95M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.35M sh · $128.01M · Q2 2026
- Remedium Capital Partners, LLC 954.15K sh · $79.47M · Q3 2026
- Avidity Partners Management LP 760.42K sh · $72.37M · Q2 2026
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 658.30K sh · $62.65M · Q2 2026
- Affinity Asset Advisors, LLC 590.00K sh · $56.15M · Q2 2026
More on Synergy Asset Management, LLC
FAQ
How long has Synergy Asset Management, LLC held ORKA?
Synergy Asset Management, LLC has disclosed ORKA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Synergy Asset Management, LLC's current position in ORKA?
As of Q3 2026, Synergy Asset Management, LLC holds 127.85K shares of ORKA (ORUKA THERAPEUTICS INC), valued at $10.65M, representing 0.98% of its reported portfolio and ranking #27.
Has Synergy Asset Management, LLC been buying or selling ORKA?
In the latest 13F filing (Q3 2026), Synergy Asset Management, LLC reduced its position in ORKA. The position peaked in Q2 2026 at 356.30K shares.
Which other funds hold ORKA?
Other major institutional holders of ORKA include Venrock Adviser, LLC, Fairmount Funds Management LLC, RTW INVESTMENTS, LP, among 87 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.